Gene expression correlation, protein-protein interaction and other high-throughput experiments in the post-genomic era have revealed that genes tend to form complex, scale-free networks where most genes have a few connections with others and a few have a high number of interactions, commonly referred to as "hubs", establishing them as important central genes in these gene networks[@b1]. These highly interconnected genes have become the targets of intense research expecting them to play prominent roles in genetic diseases. However, measurements found only a weak correlation between disease genes and hubs, e.g. Barabasi *et al*.[@b2] found that disease genes have 32% more interactions with other proteins than non-disease genes, arguing that genetic mutations in topologically central, widely expressed genes are more likely to result in severe impairment of normal development, leading to lethality in utero and eventual deletion from the population[@b2].

This is apparently not the case in schizophrenia, a disease that steadily affects about one percent of the population despite the lower fecundity of the affected individuals[@b3]. In most cases of schizophrenia no known mutations exist in protein-coding genes[@b4] and the role of gene expression dysregulation in schizophrenia is increasingly recognized[@b5][@b6].

A recent meta-analysis, examining the mutations in the genomes of 36,000 schizophrenics, identified 108 distinct genomic regions with significantly higher mutation rates[@b7]. We integrated this set with gene expression data from the Allen Brain Atlas[@b8][@b9]. After determining the correlating and anti-correlating neighbors of genes in the 108 loci we found that the median number of correlating neighbors were about **35 times** higher for the genes in the 108 regions than in the rest of the genome (**32 times** for the anti-correlating pairs).

We also integrated the data with a recent methylome study in schizophrenics[@b10]. Ranking the genes for the hypermethylated probes of the positively correlating gene pairs identified the top gene as *SYNGR1*, a synapse-related gene whose regulatory region overlaps with one of the 108 SNP-rich loci in ref. [@b7]. Ranking the genes for the hypermethylated probes of the negatively correlating gene pairs identified *MBP* and *MOBP*. They are both myelin-related, anti-correlating with a large number of synapse-related and glutamate receptor genes, offering a model that connects these frequently observed but so far disjoint pathologies in schizophrenia.

Results
=======

Genes in the most mutated genomic regions have the highest number of correlating partners
-----------------------------------------------------------------------------------------

In the first step we identified all human gene expression pairs with a Pearson correlation of \>=0.8 or \<=−0.7 in human brain tissues using the Allen Brain Atlas (website: brain-map.org)[@b8][@b9], and a recent database with pre-calculated Pearson correlations for all relevant gene pairs at <http://www.szdb.org/download.html#coexpression> by Wu *et al*.[@b11]. This resulted in 1,257,407 positively correlating and 1,108,585 negatively correlating unique gene pairs belonging to 16829 and 16761 individual genes, respectively ([Supplementary Tables 1](#S1){ref-type="supplementary-material"} and [2](#S1){ref-type="supplementary-material"}).

Subsequently we mapped all known human genes in 108 highly mutated human genomic regions identified in ref. [@b7] separately for genes whose promoters or only *cis* regulatory elements fall into these 108 loci. Filtering for genes present in the correlating or anti-correlating pairs by Wu *et al*.[@b11] resulted in 254 promoter-selected and 462 cis-selected genes (indicated by 1p/1c in [Supplementary Tables 1](#S1){ref-type="supplementary-material"} and [2](#S1){ref-type="supplementary-material"}, respectively).

Counting the positively and negatively correlating partners for all the genes except in the 108 loci in ref. [@b7] resulted in a median number of 71 positively and 63 negatively correlating pairs, respectively ([Fig. 1](#f1){ref-type="fig"}). Unexpectedly, the median numbers of correlating pairs for the promoter-selected genes were 2472 and 2013, corresponding to a **35**-fold and **32**-fold increase for the positive and negative pairs, respectively.

The number of correlating pairs for the *cis*-selected genes also proved to be higher (386 and 320 pairs on average for positively and negatively correlating pairs, respectively), corresponding to an approximately 2.5-fold increase when compared to the general gene population. The median values were similar to the average gene population in this category ([Fig. 1](#f1){ref-type="fig"}) but an unpaired t-test showed that the *cis*-derived genes and the general gene population (excluding the 108-loci genes) are significantly different (p*-*value = 0.012).

We also investigated the number of differentially methylated gene pairs using a table of 56001 differentially methylated probes from a genome-wide methylome study in schizophrenics[@b10]. We counted separately the number of hypermethylated and hypomethylated genes for the highly correlating and anti-correlating gene pairs and also the total sum of hyper- and hypomethylated probes belonging to these genes. The sums of scores for both the number of differentially methylated gene pairs and the total sum of their differentially methylated probes are shown in [Supplementary Tables 1](#S1){ref-type="supplementary-material"} and [2](#S1){ref-type="supplementary-material"}, for the positively and negatively correlating pairs, respectively.

To determine which measurement distinguishes the best between schizophrenia-related and non-specific genes we calculated the effect size for the 108-loci genes and also for genes annotated by Genecards and Malacards[@b12][@b13] as schizophrenia-related ([Fig. 2](#f2){ref-type="fig"}), using Cliff's delta for five different measurements (see legend for details).

[Figure 2a and b](#f2){ref-type="fig"} shows the effect sizes for all relevant pairs of complementary gene sets (i.e. promoter-derived *vs.* non-promoter-derived, Genecards *vs.* non-Genecards genes, etc.) comparing the numbers of correlating gene partners in one set to the numbers of the gene partners in the other gene set. As expected the promoter-derived 108-loci genes had the greatest effect size, followed by Malacards and Genecards, the 108-loci cis-derived genes having the smallest effect. The results were similar for the negatively correlating pairs ([Fig. 2b](#f2){ref-type="fig"}). Here we also filtered for gene pairs that were both differentially methylated in ref. [@b10], which increased the effect size by 0.039 for "pairs" in [Fig. 2](#f2){ref-type="fig"} for the promoter-derived positive set and by 0.061 for the same for the negative set. (Unfiltered charts shown in [Supplementary Figure 1A,B](#S1){ref-type="supplementary-material"}).

Specific genes with high numbers of correlating partners
--------------------------------------------------------

We ranked all genes according to the number of hypermethylated probes (taken from ref. [@b10]) of the correlating gene partners. [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"} show the top 20 genes with the most hypermethylated probes, in the positively and negatively correlating partners, respectively. The top-ranking gene in [Table 1](#t1){ref-type="table"} is *SYNGR1*, synaptogyrin, followed by *GRIN1*, a glutamate receptor and *CHRNB2*, a cholinergic receptor. All three genes have synapse-related functions, *SYNGR1* and *GRIN1* regulate synaptic plasticity whereas *CHRNB2* regulates synapse assembly[@b14].

*SYNGR1* is also present in the 108 most mutated loci in ref. [@b7] although only for its regulatory region, not for its promoter. Further functional analysis identified 5 more synapse-related genes in [Table 1](#t1){ref-type="table"}: *NISCH* regulates synaptic transmission, *RIMS1* and *STX1A* regulate postsynaptic potential, *CPLX2* regulates synaptic plasticity and *GRIA1* regulates long-term synaptic depression.

Altogether 11 out of the 20 genes in [Table 1](#t1){ref-type="table"} are annotated in Genecards as schizophrenia-related and 14 appear in the 108 genomic regions in ref. [@b7]. The only gene in [Table 1](#t1){ref-type="table"} that appears in neither is *ARHGEF11*, a glutamate transport enhancer, however it had a significantly higher expression in the thalamus of schizophrenics in ref. [@b15].

[Table 2](#t2){ref-type="table"} lists the top 20 genes with the highest number of hypermethylated probes for the negatively correlating partners. The top-ranking gene, *DBI*, is a GABA receptor modulator; its role having been contemplated in schizophrenia[@b16] the authors concluded that *DBI* might have a symptom modulatory rather than an etiological role in schizophrenia. Unexpectedly, *MOBP*, myelin-associated oligodendrocyte basic protein and *MBP*, myelin basic protein, both appear in [Table 2](#t2){ref-type="table"}. While myelin-related abnormalities are one of the hallmarks of schizophrenia, surprisingly, not much functional information is available about *MOBP* beyond its role in the formation of the myelin sheath[@b17] and a knockout mouse was phenotypically indistinguishable from the wild type[@b18]. Nevertheless, the authors argue that *MOBP* probably has a so far undiscovered function, due to the conservation of several alternatively spliced variants in rat and mouse[@b18].

Altogether, 11 of the 20 genes with the greatest numbers of hypermethylated probes for their anti-correlating gene partners ([Table 2](#t2){ref-type="table"}) are annotated as schizophrenia-related in Genecards and 10 appear in the 108 loci in ref. [@b7].

Interestingly, several genes in both tables are cancer-related (indicated with a "\*" next to the gene identifiers in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}). Among the top 20 genes for hypermethylated probes of correlating partners are *ARHGEF11*[@b19][@b20] and *SREPF2*, both associated with prostate and breast cancer[@b21][@b22] while *ALDOA* functions as an oncogene in highly metastatic pancreatic cancer[@b23]. *NISCH* has a tumor-suppressive function in breast cancer[@b24], *CHGB* is associated with aggressive VHL-associated pancreatic neuroendocrine tumors[@b25]. *SEZ6L2* is a prognostic marker for lung cancer[@b26], *SLC45A1* is deleted in neuroblastoma[@b27]. *GRIA1* might play a role in glioma proliferation[@b28] while *TCF20* is again associated with prostate[@b29] and breast cancer[@b30].

Among the top 20 genes for hypermethylated probes of anti-correlating partners are *RRAS*, an oncogene, also involved in neuronal axon guidance[@b31] and *MBP*, associated with oligodendrogliomas[@b32]. *TMEM219* regulates apoptosis[@b33]; *CDK2AP1* is a putative oral cancer suppressor[@b34]; *PSMB10*, a proteasome subunit, is upregulated via the NFKB1 pathway in cancer cells[@b35]. *S100A1* is also associated with several tumor types and inhibits apoptosis in ventricular cardiomyocytes[@b36].

*DGCR6* is associated with DiGeorge syndrome, a consequence of microdeletions in chromosomal region 22q11.2 and also has increased levels in metastatic mammary tumour cells[@b37]. *FABP7* plays a role in neurogenesis and is a marker of glioma stem cells[@b38]. Epithelial splicing regulatory protein 2 (*ESRP2*) suppresses cancer cell motility[@b39]. *ALDH1A1* is a marker and prognostic factor for several human cancers, bladder[@b40], pancreatic[@b41], lung[@b42], colorectal and breast cancer[@b43], among others.

Altogether, 10 genes among the top 20 for the greatest number of hypermethylated probes for the positively correlating gene partners ([Table 1](#t1){ref-type="table"}) and 13 of the 20 genes with the greatest numbers of hypermethylated probes for their anti-correlating gene partners ([Table 2](#t2){ref-type="table"}) are annotated as cancer-related in Genecards.

The connection between the positive and negative hubs
-----------------------------------------------------

The existence of the two kinds of hub genes with high numbers of positive or negative correlating partners raises the question about their functionality and the underlying neurobiological pathways: are they related or do they form mostly separate networks? To answer this question we constructed three gene networks ([Fig. 3](#f3){ref-type="fig"}): two representing the positive and negative correlations only for *SYNGR1* and *MOBP*, respectively ([Fig. 3a,b](#f3){ref-type="fig"}), and one ([Fig. 3c](#f3){ref-type="fig"}) showing a combined network of the two. We chose *SYNGR1* for the positive hub for it is the top ranking gene in [Table 1](#t1){ref-type="table"} and is also located in one of the PGC regions whereas we chose MOBP because it ranks highly among the anti-correlating genes, indicating a putative regulatory function, which, however, has not been observed yet experimentally.

To reduce the size of the networks we selected only Malacards-annotated schizophrenia-related genes that are hypermethylated in ref. [@b10]. *SYNGR1* correlates positively with 49 genes ([Fig. 3a](#f3){ref-type="fig"}); *MOBP* also has 49 negatively correlating partners ([Fig. 3b](#f3){ref-type="fig"}). The combined network is shown in [Fig. 3c](#f3){ref-type="fig"}. Strikingly, 41 genes are shared interacting partners between *MOBP* and *SYNGR1*. Each of the two hub genes interacts with only 8 genes that are not shared with the other hub. Clearly, the positive and negative correlations - and such interactions -- form highly interconnected networks that provide synaptic functions, the core functionality of the human brain.

The shared genes reflect remarkably on the nature and most consistently observed features of schizophrenia: 6 shared genes are glutamate receptors (*GRIA4, GRIK3, GRIK5, GRIN1, GRM1, GRM2*), one GABA receptor (*GABBR1*), a cannabinoid receptor (*CNR1*), *GAD2*, a glutamate decarboxylase, two synapse-related (*SYN2, SYT11*) and several neuron-specific genes are also present among the shared genes ([Fig. 3c](#f3){ref-type="fig"}).

We repeated the selection process replacing the Malacards-genes with the 108-loci genes. This resulted in a similar number of interacting genes that correlate positively with *SYNGR1* (50 genes) and negatively with *MOBP* (48 genes). They share 39 common genes ([Fig. 4](#f4){ref-type="fig"}). Biological processes derived from a Gene Ontology[@b44] analysis of the shared genes either in the Malacards set or the 108-loci set and in both cases shared between *SYNGR1* and *MOBP* and significantly enriched (p-value \< 0.05) for both sets are shown in [Table 3](#t3){ref-type="table"}. For both gene sets the top two biological processes with the highest significance are "synaptic transmission" and "modulation of synaptic transmission".

Functional analysis of schizophrenia genes correlating with the top 20 hub genes
--------------------------------------------------------------------------------

To get a further insight into the biological processes the top ranking genes and their network neighbors (i.e. their correlating and anti-correlating gene partners) partake in we took the top 20 genes with the most hypermethylated probes for the correlating (and anti-correlating) gene partners and selected those gene neighbors that correlated with *minimum* 19 of the top 20 genes. This resulted in 421 genes for the positively correlating set and 460 genes for the negatively correlating one.

For this *in silico* functional analysis we used an online tool provided by STRING[@b45] to identify Gene Ontology terms that are over-represented in our gene set. The positive gene set was associated with 278 significantly enriched GO terms for biological processes while the negative set had 151 such GO terms. Interestingly, while the two gene sets share only 117 common genes i.e. about 1/4^th^ of the total gene number for either set, they also share 117 common biological processes ([Table 4](#t4){ref-type="table"}), a much higher fraction for either set (42% of the positive set-derived biological processes and 77% of the negative set-derived processes are shared).

This result also shows that gene networks as a whole are remarkably redundant, i.e. similar functions are often carried out by several functional homologs in the brain. This network view of the genes associated with schizophrenia is also revelatory for the polygenic nature of schizophrenia: once a mutation perturbs the expression of a highly connected hub gene with many interacting partners, this in turn will lead to the perturbation of several hundred or even thousand interacting genes. The differential methylation of several thousands of genes in the prefrontal cortex of schizophrenics might be one such manifestation of the complexity of the disease.

The shared GO terms ranked by significance are listed in [Table 4](#t4){ref-type="table"}. The top process is "nervous system development", followed by "synaptic transmission", reflecting two major aspects of schizophrenia, i.e. it is considered a (neuro)developmental disease[@b46] affecting mostly the synapse[@b47]. On a different note, the most frequently occurring word in [Table 4](#t4){ref-type="table"} is "regulation" (occurring 29 times), followed by "transport" (24x), perhaps underlining somewhat less pronounced aspects of schizophrenia.

Positive hub genes are longer, negative hub genes are shorter than average
--------------------------------------------------------------------------

We also calculated the protein length and protein disorder statistics for both the top 20 positive and negative hubs. Surprisingly, while the top 20 positive hub proteins were significantly longer (p-value \< 10^−5^) than the average human protein (894 and 442 amino acids, on average, respectively), the top 20 negative hub proteins were significantly shorter (327 amino acids on average). We did not find their disorder to be significantly different from that of the general human protein population. Likewise, the 108 region-derived proteins among the top 20 positive and negative hubs in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}, were also longer (14 proteins in [Table 1a](#t1){ref-type="table"} with an average length of 983 amino acids) and shorter (10 proteins in [Table 1b](#t1){ref-type="table"} with an average length of 261), respectively, than the average human protein (442 aa).

Discussion
==========

It has been known for at least a decade that myelin has an inhibitory role in axonal regeneration[@b48] in the CNS. Myelin is dysfunctional in schizophrenia[@b49] and this dysfunctionality leads to changes in synaptic formation and function, another hallmark of schizophrenia[@b49]. Several studies have identified genes whose expression is abnormal in schizophrenic brains affecting myelin-related[@b50] and synapse-related biochemical pathways[@b47]. However, this is the first time, to our knowledge, that a model for a complete network of gene interactions is presented that would account for both of these recurring anomalies in schizophrenia.

Our gene network has two hubs, one, *SYNGR1*, with a synaptic function, correlates positively and apparently interacts with a high number of genes that also interact with one another and at the same time interact negatively with *MOBP*, a myelin gene. Myelin is known to inhibit axonal sprouting, a step considered important for synaptic formation[@b51]. While neither *MOBP*, nor *MBP* are known to have such inhibitory functions, another myelin-related protein, *RTN4* (also called Nogo-A), ranking 88th among the negatively correlating genes ([Supplementary Table 2](#S1){ref-type="supplementary-material"}), does have such a function, inhibiting axon growth[@b51]. It is tempting to hypothesize that either *MOBP* or *MBP* also have such a - so far undiscovered - inhibitory function. *MOBP* is the 3^rd^ most abundant protein in the CNS myelin and has several alternatively spliced variants. As highlighted by Montague *et al*.[@b18] a physiological function for *MOBP* has not been found yet. Our model with two antagonistic hub genes would also account for the antagonistic relationship between myelin genes and synapse-related functions[@b52].

We also found a high representation of cancer-related genes in both the top correlating and anti-correlating genes ([Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}). While only limited association has been found so far connecting schizophrenia- and cancer-related gene hubs[@b53], there are several studies pinpointing the essential role of hub proteins in cancer[@b2][@b54]. Only a handful of papers have been published on gene networks in schizophrenia, e.g. a study highlighting shared hubs and gene networks between schizophrenia and diabetes[@b55] and our own work on microRNA-driven networks and hub genes in schizophrenia[@b56]. Perhaps the most relevant study connecting cancer- and schizophrenia-related gene networks is by Ibanez *et al*.[@b57] who found an inverse comorbidity between the two diseases, observing expression deregulations in opposite directions of the same genes and gene networks.

Our model is also supported by the extraordinary enrichment of correlating partners for the genes encoded in the 108 genomic regions with the highest mutation rates in the genomes of schizophrenics identified in ref. [@b7]. As mentioned above, the median number of correlating partners for those genes whose promoters are located in the 108 loci is 35 times higher for the positively correlating genes than for the rest of the genes in this study and 32 times higher for the negatively correlating genes. The effect size for these comparisons is in the range of 0.8--0.9, making the number of interacting partners, reflecting the centrality of a gene, the single most important factor when considering the biological significance of the individual schizophrenia-related genes and their contribution to the disease. There is a significant but smaller enrichment (2.5 times on average) for those 108-loci genes whose promoters are not, only their enhancers are present in these loci, which raises the intriguing possibility that for most genes in this set the mutations fall into or close to the promoter regions, compromising their functionality as in most cases of schizophrenia the protein sequences are not corrupted by mutations.

The assumption that it is the regulatory regions, not the protein-coding regions that are affected mostly in schizophrenia is also apparent in the fact that despite the strong centrality ("hubness") of the affected genes we do find surviving phenotypes, which are the patients, exactly. As raised in the introduction, hub genes with a mutation in the coding region would make these mutations lethal in most instances[@b2].

The robustness of our findings is also supported by the fact that when we replace the Malacards genes with the 108-loci genes in [Fig. 3](#f3){ref-type="fig"} (sharing only *SYNGR1, SRR* and *NRGN* as indicated in [Fig. 3](#f3){ref-type="fig"}) and analyze the Gene Ontology terms for the 39 genes correlated positively by *SYNGR1* and negatively by *MOBP*, we find that the most significant biological process associated with this gene set is again "synaptic transmission". This also shows the remarkable redundancy of the gene networks in the human brain. Altogether, beyond providing an intriguing new model for schizophrenia, with more details for the underlining gene networks than before, it is also fascinating and quite fitting that synaptic transmission, perhaps the most complex and dynamic part of the human brain also entails the most genetic complexity, i.e. the most connected gene networks with the highest number of correlating/interacting gene partners.

Methods
=======

Determining pairwise gene expression correlations in the human brain
--------------------------------------------------------------------

In the first step all pairwise Pearson correlations were determined for those genes expressed in the brain that have expression data in the Allen Brain Atlas (website: brain-map.org)[@b8][@b9]. Gene expression was measured for 50,000 genes in 524 different tissues taken from several compartments of the brains of several individuals spanning the human lifetime between 2 weeks of post-conception and 40 years of age. We used an in-house Perl script to calculate pairwise correlations complemented by correlation data taken from SZDB.org[@b11]. We filtered the results keeping only pairwise Pearson correlation that were either minimum 0.8 or maximum −0.7. If there were several values for the same gene pair we used the most extreme ones, the highest and lowest values for the positive and negative correlations, respectively.

We mapped all known human genes in 108 highly mutated human genomic regions identified in ref. [@b7] separately for genes whose promoters or only *cis* regulatory elements fall into these 108 loci. We determined the location of the promoters and cis elements in the human genome using a study by Thurman *et al*.[@b58].

Counting correlating gene pairs and their differentially methylated probes
--------------------------------------------------------------------------

For each gene whose expression correlated (r \>= 0.8) or anti-correlated (r \<= −0.7) with other genes in our data set (16830 and 16762 genes with correlating and anti-correlating partners, respectively) we counted the number of correlating and anti-correlating partners. Using a methylome data set in ref. [@b10] that recorded 56001 differentially methylated probes between two subgroups of schizophrenia patients we also counted gene partners for each gene that were hypermethylated or hypomethylated (with at least one hypermethylated or hypomethylated probe, respectively) and also the total number of hyper- or hypomethylated probes for the correlating and anti-correlating gene partners. The genes were ranked for the total sum of hypermethylated probes of the 'neighboring' (i.e. either correlating or anti-correlating) genes as this ranking placed *SYNGR1*, a gene present with its regulatory region in the 108 SNP rich regions in schizophrenics, identified by the Psychiatric Genomics Consortium (PGC) to the top of the list (in [Table 1](#t1){ref-type="table"}). This ranking also produced 14 genes out of the top 20 genes in [Table 1](#t1){ref-type="table"} with either its promoter or cis-regulatory region overlapping with the SNP-rich PGC regions in ref. [@b7].

Determining the effect size to distinguish between schizophrenia-related and unrelated genes
--------------------------------------------------------------------------------------------

To determine which measurement distinguishes the best between schizophrenia-related and non-specific genes we calculated the effect size for the 108-loci genes and also for genes annotated by Genecards and Malacards[@b12][@b13] as schizophrenia-related ([Fig. 2](#f2){ref-type="fig"}) regarding each specific feature mentioned in the previous paragraph (i.e. the number of correlating genes, the number of hypermethylated, hypomethylated correlating genes and the total sum of the differentially methylated probes of the correlating pairs). We repeated the calculations for the negatively correlating pairs as well. To calculate the effect size we used Cliff's delta. Cliff's delta is defined as

where the two distributions are of size **m** and **n** with items **x**~**i**~ and **x**~**j**~ (with ***i*** running from **1 to m** and ***j*** running from **1 to n**) respectively, and \# is defined as the number of times. Cliff's delta shows that out of all possible pairwise comparisons between the numbers in set **A** and set **B** in what proportion will the numbers in set **A** be bigger than in set **B**. Cliff's delta does not require any assumptions about distribution types.

Functional analysis with the Gene Ontology module of STRING
-----------------------------------------------------------

To carry out functional analysis of the top 20 genes and their network neighbors we used the Gene Ontology (GO) module[@b14] of the STRING[@b45] webserver. The server lists all functional categories that are significantly enriched in the provided gene set, and supplies the corresponding p-values. We recorded the biological processes for the top 20 positive and negative genes and also their network neighbors.

Network visualization, statistical calculations
-----------------------------------------------

To visualize the gene correlation networks in [Figs 3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"} Cytoscape[@b59] was used. To carry out t-test calculations and calculate the corresponding p-values we used cpan's Statistics package, a Perl library. Whenever not mentioned explicitly, calculations and data manipulation was carried out with in-house Perl script (available on request from the author).
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![Boxplots of inteacting partners for all genes and promoter-selected and cis-selected genes in 108 SNP-rich genomic regions taken from ref. [@b7].\
(**A**) Positive, (**B**) negative correlating partners.](srep45494-f1){#f1}

![The effect sizes for the ratios of gene neighbor numbers between specific genes and their complementary gene sets (i.e. the rest of the \~16 k genes present in the study): 108-loci cis genes; Malacards-annotated schizophrenia genes; Genecards-annotated schizophrenia genes; 108-loci promoter genes.\
Effect sizes were calculated for 5 different measurements: (i) **pairs**, the total number of correlating gene pairs; (ii) **pairs_hypometh**, the number of correlating gene pairs that are hypomethylated (defined as in at least one probe the gene is hypomethylated); (iii) **pairs_hypermeth**, the number of correlating gene pairs that are hypermethylated; (iv) **pairs_hypoSum**, the total number of hypomethylated probes of the correlating gene pairs; (v) **pairs_hyperSum**, the total number of hypermethylated pairs for the correlating gene pairs. The numbers were filtered using only pairs of genes where both genes were differentially methylated in ref. [@b10]. (**A**) Positively, (**B**) Negatively correlating gene pairs.](srep45494-f2){#f2}

![Gene networks of hub genes generated from hypermethylated Malacards-annotated genes.\
(**A**) SYNGR1-centered, positively correlating gene network. The red-colored edges show correlations with SYNGR1. (**B**) Negatively correlating gene network, centered on MOBP. All the red-colored edges show negative correlations with MOBP. All the other pairwise negative correlations are shown in grey. The purple-colored genes overlap with 108 highly mutated genomic loci in schizophrenics (see text for details). (**C**) The combined network in (**A** and **B**). All light green-colored genes correlate positively with SYNGR1 and negatively with MOBP. The purple-colored and turquoise-colored genes correlate only with MOBP or SYNGR1, respectively.](srep45494-f3){#f3}

![(**A**) All positively correlating genes in the 108 loci. The network is again centered on *SYNGR1*. The red-colored edges show correlations with *SYNGR1*. (**B**) All the genes in the 108 loci that correlate negatively with *MOBP* (edges colored red) or one another (grey edges). (**C**) The combined network in (**A** and **B**). All light green-colored genes correlate positively with *SYNGR1* and negatively with *MOBP* (edges show in red in both cases). The purple-colored and turquoise-colored genes correlate only with *MOBP* or *SYNGR1* (of the two), respectively.](srep45494-f4){#f4}

###### The top 20 positively correlating genes, ranked according to the hypermethylated probes (listed in column 6) in the correlating gene partners.

  gene            pairs   pairs hypo meth   pairs hyper meth   pairs hypo Sum   pairs hyper Sum   probes hypo   probes hyper   genecards Score   malacards Score   prom/ cis?   prot len                  description
  -------------- ------- ----------------- ------------------ ---------------- ----------------- ------------- -------------- ----------------- ----------------- ------------ ---------- -------------------------------------------
  **SYNGR1**      4336         1437               2086              3553             8290              0             8            **8.57**             NA            **1c**       233                   synaptogyrin 1
  **GRIN1**       3800         1261               1915              3302             7959              2             1            **9.07**            7.55             NA         959       glutamate receptor, ionotropic, NMDA 1
  **CHRNB2**      4070         1391               1992              3465             7880              1             3            **9.07**            5.10             NA         502       cholinergic receptor, nicotinic beta 2
  ARHGEF11\*      4024         1394               1951              3506             7832              0             3               NA                NA              NA         1562     Rho guanine nucleotide exchange factor 11
  **ALDOA\***     4949         1558               2208              3983             7811              2             5            **−2.01**            NA            **1p**       418          aldolase, fructose-bisphosphate A
  **SREBF2\***    3750         1295               1810              3352             7643              1             0            **−1.79**            NA            **1c**       1141      sterol regulatory element binding TF 2
  **PITPNM2**     3308         1202               1734              3188             7626              2             18           **−2.01**            NA            **1p**       1349       phosphatidylinositol transfer protein
  GRAMD1B         4159         1428               1980              3418             7569              2             6               NA                NA            **1c**       745              GRAM domain containing 1B
  **NISCH\***     4152         1331               1951              3250             7495              0             3            **−1.60**            NA            **1c**       1504                     nischarin
  RIMS1\*         4679         1474               2067              3461             7465              0             3               NA                NA            **1c**       1692     regulating synaptic membrane exocytosis 1
  **CPLX2**       3433         1149               1677              3139             7345              3             5            **9.07**            2.48             NA         134                     complexin 2
  **CHGB\***      3665         1205               1746              3154             7316              1             0            **9.07**            3.83             NA         677                   chromogranin B
  **STX1A**       3941         1259               1880              3023             7283              1             6            **−0.60**            NA              NA         288                    syntaxin 1 A
  SEZ6L2\*        3406         1169               1747              3046             7265              0             1               NA                NA            **1c**       923      seizure related 6 homolog (mouse)-like 2
  L3MBTL2         4406         1361               1972              3127             7227              1             0               NA                NA            **1p**       705             l(3)mbt-like 2 (Drosophila)
  SLC45A1\*       3454         1160               1740              2988             7218              1             4               NA                NA            **1c**       782          solute carrier family 45 member 1
  **GRIA1\***     4337         1377               1950              3256             7141              0             3            **9.06**             NA            **1c**       916       glutamate receptor, ionotropic, AMPA 1
  RANGAP1         3704         1232               1772              3074             7091              0             1               NA                NA            **1p**       587           Ran GTPase activating protein 1
  TCF20\*         3497         1242               1700              3258             7044              0             1               NA                NA            **1p**       1960           transcription factor 20 (AR1)
  EPC2            5124         1514               2084              3436             6909              1             0               NA                NA            **1p**       807           enhancer of polycomb homolog 2

The total number of positively correlating genes (column 2), of which hypo- or hypermethylated (columns 3 and 4), are also listed. Genecards and Malacards scores are listed in columns 7 and 8. The column "prom/cis?" indicates if the promoter of the gene ("1p") or the cis regulatory region of the gene ("1c") falls into the 108 highly mutated loci in ref. [@b7]. A "\*" next to the gene identifier indicates a role in cancer.

###### The top 20 negatively correlating genes, ranked according to the hypermethylated probes (listed in column 6) in the anti-correlating gene partners.

  gene              pairs   pairs hypo meth   pairs hyper meth   pairs hypo Sum   pairs hyper Sum   probes hypo   probes hyper   genecards Score   malacards Score   prom/ cis?   protlen                       description
  ---------------- ------- ----------------- ------------------ ---------------- ----------------- ------------- -------------- ----------------- ----------------- ------------ --------- ------------------------------------------------------
  **DBI\***         6013         1882               2601              4400             9376             NA             NA           **−1.01**            NA              NA         143     diazepam binding inhibitor (GABA receptor modulator)
  C1orf54           5656         1792               2507              4233             9164              0             1               NA                NA              1p         131              chromosome 1 open reading frame 54
  RRAS\*            6426         1851               2669              4197             8986              1             0               NA                NA              NA         218          related RAS viral (r-ras) oncogene homolog
  **C2orf82**       6837         1948               2720              4274             8934              2             1            **−0.01**            NA              1p         121              chromosome 2 open reading frame 82
  NDUFA4L2          6517         1837               2635              4132             8668              5             1               NA                NA              1p         93        NADH dehydrogenase 1 alpha subcomplex, 4-like 2
  **MOBP**          5741         1678               2462              3622             8576              9             0            **9.07**            2.40             NA         206       myelin-associated oligodendrocyte basic protein
  **MBP\***         5467         1656               2349              3644             8266             25             8            **8.56**             NA              NA         304                     myelin basic protein
  **CDK2AP1\***     4638         1496               2120              3668             8130              5             0            **−0.79**            NA              1p         115        cyclin-dependent kinase 2 associated protein 1
  S100A1\*          4791         1529               2114              3501             7497              1             0               NA                NA              NA         147               S100 calcium binding protein A1
  **FABP7\***       3921         1299               1852              3224             7490              3             1            **0.00**             NA              NA         166             fatty acid binding protein 7, brain
  TMEM219\*         5188         1603               2153              3795             7218             NA             NA              NA                NA              1p         240                  transmembrane protein 219
  **DGCR6\***       5993         1721               2310              3836             7040              0             1            **10.48**           13.8             NA         220           DiGeorge syndrome critical region gene 6
  ESRP2\*           3767         1188               1770              2842             6828              0             1               NA                NA              1p         727           epithelial splicing regulatory protein 2
  **AS3MT**         3711         1269               1718              3120             6780              0             2            **0.22**             NA              1p         375                  arsenite methyltransferase
  ANP32E            3907         1204               1747              3092             6738              1             0               NA                NA              1p         268       acidic nuclear phosphoprotein 32 family member E
  **ALDH1A1\***     3992         1236               1815              2898             6720             NA             NA           **−1.00**            NA              NA         501          aldehyde dehydrogenase 1 family member A1
  PSMB10\*          5214         1565               2058              3579             6528             NA             NA              NA                NA              1p         273                  proteasome subunit beta 10
  HIRIP3            5503         1514               2183              3158             6524             NA             NA              NA                NA              1p         556                  HIRA interacting protein 3
  **SELENBP1\***    5044         1426               2090              2952             6514              4             0            **0.15**             NA              NA         514                  selenium binding protein 1
  **RENBP\***       5201         1438               2111              2956             6507             NA             NA           **−0.60**            NA              NA         427                    renin binding protein

The total number of positively correlating genes (column 2), of which hypo- or hypermethylated (columns 3 and 4), are also listed. Genecards and Malacards scores are listed in columns 7 and 8. The column "prom/cis?" indicates if the promoter of the gene ("1p") or the cis regulatory region of the gene ("1c") falls into the 108 highly mutated loci in ref. [@b7]. A "\*" next to the gene identifier indicates a role in cancer.

###### Biological processes shared between the Malacards gene set interacting with both *SYNGR1* and *MOBP* in [Fig. 3C](#f3){ref-type="fig"} (41 light green-colored genes) and the 108-loci genes interacting with both *SYNGR1* and *MOBP* in [Fig. 4C](#f4){ref-type="fig"} (39 light green-colored genes).

  GO_identifier           GO_Biological Process          shared Genes_108 loci   p_val (108 loci)   shared Genes Malacards   p_val (Malac Genes)
  --------------- ------------------------------------- ----------------------- ------------------ ------------------------ ---------------------
  GO:0050804       modulation of synaptic transmission             7                 0.00359                  14                  1.23e-13
  GO:0007268              synaptic transmission                    9                 0.00359                  16                  8.05e-12
  GO:0061564                axon development                       7                  0.0318                  11                  2.14e-06
  GO:0031175          neuron projection development                8                  0.0289                  11                  1.08e-05
  GO:0048167        regulation of synaptic plasticity              4                  0.0469                  6                   4.71e-05
  GO:0048666               neuron development                      9                  0.0233                  11                  4.71e-05
  GO:0048812         neuron projection morphogenesis               7                  0.0318                  9                   0.000146
  GO:0007411                  axon guidance                        6                  0.0415                  7                    0.00128
  GO:0030182             neuron differentiation                    9                  0.0318                  9                    0.00545
  GO:0044765            single-organism transport                 15                  0.0318                  15                   0.0062
  GO:0007399           nervous system development                 14                  0.0138                  12                    0.011
  GO:1902578          single-organism localization                16                  0.0289                  15                   0.0111

12 biological processes in the table are common in the two shared sets, despite the very limited number of actually shared genes (only *NRGN* is shared besides *MOBP* and *SYNGR1* but these two were not included in the GO analysis).

###### Biological processes shared between the positively correlating and negatively correlating gene neighbors of the top 20 genes in [Table 1](#t1){ref-type="table"} and [Table 2](#t2){ref-type="table"}.

  GO_identifier                         GO_Biological Process                        Pos Neighbors   p_val (Pos Neigh)   Neg Neighbors   p_val (Neg Neigh)
  --------------- ----------------------------------------------------------------- --------------- ------------------- --------------- -------------------
  GO:0007399                         nervous system development                           88             5.21e-12             105            4.23e-17
  GO:0007268                            synaptic transmission                             48             2.95e-14             49             7.45e-14
  GO:0048699                            generation of neurons                             68             1.57e-11             70             3.36e-10
  GO:0048666                             neuron development                               52             6.61e-12             52             3.78e-10
  GO:0031175                        neuron projection development                         48             2.83e-12             46             9.22e-10
  GO:0022008                                neurogenesis                                  68             1.62e-10             70             2.03e-09
  GO:0007267                             cell-cell signaling                              57             2.83e-12             53             1.32e-08
  GO:0048731                             system development                               99             0.000594             125            2.02e-08
  GO:0030182                           neuron differentiation                             56              5.4e-11             54             2.31e-08
  GO:0048667            cell morphogenesis involved in neuron differentiation             39             3.77e-10             38             2.98e-08
  GO:0048812                       neuron projection morphogenesis                        39              7.5e-10             38             5.45e-08
  GO:0061564                              axon development                                37             1.74e-09             36             1.16e-07
  GO:0007409                                axonogenesis                                  36             2.41e-09             35             1.49e-07
  GO:0007275                    multicellular organismal development                      106             0.00347             132            7.65e-07
  GO:0030030                        cell projection organization                          51             2.12e-08             50             1.66e-06
  GO:0007610                                  behavior                                    32             1.34e-06             34              1.8e-06
  GO:0048858                        cell projection morphogenesis                         42              1.1e-07             41             5.72e-06
  GO:0007156       homophilic cell adhesion via plasma membrane adhesion molecules        10              0.0277              17             7.86e-06
  GO:0048856                      anatomical structure development                        105             0.00619             128            1.01e-05
  GO:0050803                 regulation of synapse structure or activity                  28             2.83e-12             20             1.43e-05
  GO:0044767                    single-organism developmental process                     118             0.00225             138            2.61e-05
  GO:0098742          cell-cell adhesion via plasma-membrane adhesion molecules           11              0.0369              18             2.65e-05
  GO:0050804                     modulation of synaptic transmission                      27             2.94e-10             21             3.04e-05
  GO:0044708                          single-organism behavior                            26             1.07e-05             27             3.14e-05
  GO:1902580                    single-organism cellular localization                     37             0.000174             41             8.75e-05
  GO:0007626                             locomotory behavior                              19             3.27e-06             18             0.000103
  GO:0032502                            developmental process                             116             0.00628             136            0.000108
  GO:0030001                             metal ion transport                              36              3.9e-07             33              0.00011
  GO:0051650                    establishment of vesicle localization                     16             7.43e-05             17             0.000111
  GO:0051640                           organelle localization                             25             5.23e-06             24             0.000152
  GO:1902578                        single-organism localization                          116            2.83e-12             98             0.000153
  GO:0006811                                ion transport                                 46             8.77e-05             49             0.000157
  GO:0007611                             learning or memory                               16             0.000443             18             0.000177
  GO:0000902                             cell morphogenesis                               48             1.22e-07             43             0.000182
  GO:0030534                               adult behavior                                 15             3.73e-05             15             0.000195
  GO:0044765                          single-organism transport                           110            7.01e-12             93             0.000195
  GO:0050890                                  cognition                                   17             0.000535             19             0.000241
  GO:0007417                     central nervous system development                       35              0.0013              40             0.000252
  GO:0098660                    inorganic ion transmembrane transport                     34             1.76e-06             31             0.000405
  GO:0051641                            cellular localization                             76             1.56e-06             73             0.000436
  GO:0031344                 regulation of cell projection organization                   28             7.75e-06             26             0.000577
  GO:0051656                   establishment of organelle localization                    22              6.8e-06             20             0.000577
  GO:0061024                            membrane organization                             37             0.000377             39             0.000832
  GO:0051960                  regulation of nervous system development                    38              6.8e-07             33             0.000962
  GO:0048468                              cell development                                65             5.66e-07             59              0.00104
  GO:0032989                      cellular component morphogenesis                        49             5.34e-07             43              0.00118
  GO:0007420                              brain development                               28              0.00376             32              0.0012
  GO:0006810                                  transport                                   125            2.83e-12             102             0.00145
  GO:0043087                        regulation of GTPase activity                         29             6.67e-05             28              0.00148
  GO:0010975                 regulation of neuron projection development                  24              6.8e-06             21              0.00152
  GO:0045664                    regulation of neuron differentiation                      28             2.54e-05             26              0.00152
  GO:0007613                                   memory                                      8               0.032              11              0.00167
  GO:0051234                        establishment of localization                         126            6.68e-12             104             0.0017
  GO:0030154                            cell differentiation                              89              0.00066             94              0.00201
  GO:0048869                       cellular developmental process                         91              0.00124             97              0.00259
  GO:0006836                         neurotransmitter transport                           11              0.00842             13              0.00268
  GO:0044700                          single organism signaling                           139            1.56e-06             134             0.00275
  GO:0051179                                localization                                  146            2.83e-12             120             0.00276
  GO:0071702                         organic substance transport                          66             3.73e-05             64              0.00276
  GO:0060322                              head development                                28              0.00956             32              0.00351
  GO:0065008                      regulation of biological quality                        94             1.07e-05             90               0.004
  GO:1902582                   single-organism intracellular transport                    41              0.00307             44              0.00444
  GO:0043547                   positive regulation of GTPase activity                     27             9.52e-05             25              0.00452
  GO:0007154                             cell communication                               143            6.53e-07             135             0.00462
  GO:0007411                                axon guidance                                 25             3.26e-05             22              0.00462
  GO:0034220                         ion transmembrane transport                          41             3.01e-06             35              0.00483
  GO:0050767                         regulation of neurogenesis                           31             4.27e-05             28              0.00483
  GO:0007269                         neurotransmitter secretion                            9              0.0209              11              0.00491
  GO:0070838                        divalent metal ion transport                          16              0.00343             17              0.00515
  GO:0023061                               signal release                                 14              0.00137             14              0.00516
  GO:0043269                         regulation of ion transport                          39             7.33e-09             28              0.00569
  GO:0051649                    establishment of localization in cell                     68             9.18e-07             59              0.00675
  GO:0006812                              cation transport                                35             0.000182             33              0.00683
  GO:0035637                     multicellular organismal signaling                       10              0.00233             10              0.00764
  GO:0050806                positive regulation of synaptic transmission                  13             1.78e-05             10              0.00826
  GO:0044093                  positive regulation of molecular function                   55              0.00211             57              0.00829
  GO:0051336                      regulation of hydrolase activity                        51             2.23e-05             46              0.00829
  GO:0048167                      regulation of synaptic plasticity                       17             1.64e-07             11              0.00978
  GO:0098662                  inorganic cation transmembrane transport                    30             4.56e-06             24              0.0106
  GO:0008088                            axon cargo transport                               9             5.65e-06              6              0.0132
  GO:0072384                    organelle transport along microtubule                      7             0.000645              6              0.0132
  GO:0008104                            protein localization                              62             2.35e-05             56              0.0139
  GO:0045665                negative regulation of neuron differentiation                 10               0.041              12              0.0139
  GO:0007264                  small GTPase mediated signal transduction                   33             7.44e-05             29              0.0144
  GO:0023051                           regulation of signaling                            76              0.00514             80              0.0146
  GO:0031345             negative regulation of cell projection organization              10              0.00473             10              0.0146
  GO:0001764                              neuron migration                                11              0.00124             10              0.0154
  GO:0015031                              protein transport                               51             1.07e-05             44              0.0154
  GO:0043085                  positive regulation of catalytic activity                   49              0.00174             49              0.0159
  GO:0098655                       cation transmembrane transport                         33             1.16e-05             27              0.0159
  GO:0010646                      regulation of cell communication                        88             5.43e-05             83              0.0163
  GO:0010977            negative regulation of neuron projection development               8              0.0226               9              0.0163
  GO:0045184                    establishment of protein localization                     53             1.32e-05             46              0.0166
  GO:0001508                              action potential                                 9              0.00602              9              0.0172
  GO:0006816                            calcium ion transport                             14              0.00545             14               0.019
  GO:0044802                    single-organism membrane organization                     28              0.00842             29              0.0227
  GO:0033036                         macromolecule localization                           69             5.82e-05             63              0.0246
  GO:0055085                           transmembrane transport                            49             1.53e-06             39              0.0251
  GO:0035556                      intracellular signal transduction                       65             3.26e-05             58              0.0265
  GO:0046907                           intracellular transport                            47              0.00101             45              0.0265
  GO:0051899                           membrane depolarization                             7               0.01                7              0.0265
  GO:0065009                      regulation of molecular function                        80              0.00064             78               0.027
  GO:0007612                                  learning                                    10               0.01               10              0.0298
  GO:0048489                         synaptic vesicle transport                           10              0.00296              9              0.0324
  GO:0050773                     regulation of dendrite development                       11              0.00066              9              0.0324
  GO:0032940                              secretion by cell                               22              0.00835             22              0.0356
  GO:0051345                  positive regulation of hydrolase activity                   41             3.94e-06             32              0.0358
  GO:0060284                       regulation of cell development                         36             5.56e-05             30              0.0365
  GO:0097479                        synaptic vesicle localization                         11             0.000782              9              0.0365
  GO:0050790                      regulation of catalytic activity                        67              0.00203             66              0.0383
  GO:0050770                         regulation of axonogenesis                           10               0.014              10              0.0405
  GO:0034765                  regulation of ion transmembrane transport                   31             1.05e-08             19              0.0418
  GO:0050807                     regulation of synapse organization                       14             6.24e-06              9              0.0426
  GO:0035725                     sodium ion transmembrane transport                       12              0.00121             10              0.0438
  GO:0016043                       cellular component organization                        125            0.000226             121             0.0456
  GO:0047496                     vesicle transport along microtubule                       4              0.0215               4              0.0457
  GO:0051128                regulation of cellular component organization                 76             3.59e-06             64              0.0495
